A multi-cancer blood test, in plain English
A multi-cancer blood test looks for traces that tumours can release into the blood, such as fragments of DNA, and checks for a signal from many cancer types at once. Where it finds one, it may suggest where in the body the signal comes from.
It is an emerging test, and none has been authorized by the FDA. A positive result needs imaging and other tests to confirm it, a negative result does not mean no cancer is present, and it is offered in addition to guideline cancer screening rather than instead of it. Multi-cancer early detection blood testing is offered under brands like Galleri.
Cancer in Stamford-White Plains, by the numbers
The rate of past cancer diagnoses in Stamford-White Plains is about the same as the national rate. About 1 in 12 adults in Stamford-White Plains have ever been diagnosed with cancer, other than common skin cancers, compared with about 1 in 13 nationally. That adds up to roughly 130,000 adults across two counties and two Connecticut planning regions.
By area
| Area | Cancer (other than skin cancer) | Colorectal screening up to date (ages 45 to 75) | Mammogram in the past 2 years (women 50 to 74) |
|---|---|---|---|
| Westchester | 8.1% | 68.1% | 81.4% |
| Western Connecticut (planning region) | 8.4% | 72.4% | 78.6% |
| Greater Bridgeport (planning region) | 7.4% | 69.9% | 78.0% |
| Putnam | 9.3% | 73.0% | 79.7% |
| Stamford-White Plains | 8.1% | 69.9% | 79.9% |
| United States | 7.8% | 63.8% | 76.1% |
Source: CDC PLACES, 2022 and 2023 county estimates. Stamford-White Plains = Westchester and Putnam counties and the Western Connecticut and Greater Bridgeport planning regions, weighted by adult population.
longevityclinicshub.comYour regular doctor can tell you which standard screenings are due for your age. Those come first, and the newer tests above are extras, not replacements.

